Close
Healx, a U.K.-based startup specializing in AI-enabled drug discovery for rare diseases, has successfully raised $47 million in a Series C funding round. This funding was co-led by Atomico and R42, and it positions Healx to initiate Phase 2 clinical trials for a new drug targeting Neurofibromatosis Type 1 (NF1) later this year. The company utilizes AI to uncover hidden connections between existing drugs and rare diseases, streamlining the drug discovery process.
The funding will support the development of HLX-1502, a reformulated drug aimed at treating NF1, which affects approximately 1 in 3,000 individuals. Healx's innovative approach contrasts with traditional pharmaceutical methods by analyzing vast datasets to identify potential treatments more efficiently. With a focus on minimizing side effects, Healx aims to provide safer alternatives for patients with benign tumors associated with NF1.
• Healx raises $47 million for AI-driven drug discovery.
• Company prepares for Phase 2 trials of HLX-1502 for NF1.
Healx employs AI to analyze complex biological data and discover novel treatments for rare diseases.
Healx creates a biomedical knowledge graph to identify connections between drugs and rare diseases.
Healx's digital chemistry team utilizes generative chemistry to match disease signatures with suitable drugs.
Healx aims to revolutionize the drug development process by leveraging AI to find new treatments for conditions that lack effective therapies.
Atomico co-led Healx's Series C funding round, demonstrating confidence in Healx's innovative approach to drug discovery.
R42's participation in Healx's funding round highlights the growing interest in AI applications in healthcare.
The Wall Street Journal 6month
Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600
How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.
Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.
Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.
Log in
Sign Up
AI Tools - Popular
AI Tools - Categories
GPTs - Categories
AI for Jobs
Key AI Highlights in this Article
Key AI Terms Mentioned in this Article
Companies Mentioned in this Article
